フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following ...
Shield Therapeutics PLC 21 November 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Business Update Recruitment...
Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flo ...
Shield Therapeutics PLC 29 October 2024 The information contained within this announcement is deemed by the Company to constitute inside...
Shield Therapeutics PLC 25 September 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Results from Phase 3...
Shield Therapeutics PLC said on Wednesday that its revenue had multiplied threefold, but an increased cost of sales a ...
Shield Therapeutics PLC 04 September 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Interim results for the six...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Shield Therapeutics PLC 27 August 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") ACCRUFeR® Approved by Health...
Shield Therapeutics PLC 14 August 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Notice of interim results ...
The following is a round-up of London-listed company director and manager changes announced on Wednesday and Thursday ...
Shield Therapeutics PLC 24 July 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Unaudited Q2 2024 Trading Update ...
Shield Therapeutics PLC 24 July 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Directorate Change London, UK...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...
Shield Therapeutics PLC 03 July 2024 Shield Therapeutics plc ("Shield" or the "Company" or the "Group") Shield Enters into $5.7 million...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約